Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2026-05-19 16:05:08 ET · period of report 2026-05-15 · accession 0001376043-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-19 16:05 | 2026-05-15 | TVTX | Coughlin Timothy | Dir | S - Sale | $43.49 | -3,250 | 52.2K | -6% | -$141.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-15 | S | D | 3,250 | $43.49 | 52,250 | D | — | — | (F1) This sale was made pursuant to a written plan adopted on November 19, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. |